TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells

Journal of Nephrology

Volumn 26, Issue 5, 2013, Pages 886-893

  Imaizumi, Tadaatsu ^a   Aizawa Yashiro, Tomomi ^a   Watanabe, Shojiro ^a   Matsumiya, Tomoh ^a   Yoshida, Hidemi ^a   Tatsuta, Tetsuya ^a   Xing, Fei ^a   Meng, Pengfei ^a   Hayakari, Ryo ^a   Tsuruga, Kazushi ^a   Tanaka, Hiroshi ^a,b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

CXCL10; LPS; MDA5; Mesangial cells; RIG I; TLR4

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5 PROTEIN; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; DDX58 PROTEIN, HUMAN; DEAD BOX PROTEIN; IFIH1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TLR4 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESANGIUM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; PROCEDURES;

CELLS, CULTURED; CHEMOKINE CXCL10; DEAD-BOX RNA HELICASES; HUMANS; INTERFERON-BETA; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MESANGIAL CELLS; RNA, MESSENGER; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84880588616     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000254     Document Type: Article

References (38)

1. Shimosawa M, Sakamoto K, Tomari Y, et al. Lipopolysaccharide-triggered acute aggravation of mesangioproliferative glomerulonephritis through activation of coagulation in a high IgA strain of ddY mice. Nephron Exp Nephrol. 2009; 112(4): e81-e91.
2. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol. 2010; 87(6): 989-999.
3. Richez C, Blanco P, Rifkin I, Moreau J-F, Schaeverbeke T. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine. 2011; 78(2): 124-130.
4. Allam R, Scherbaum CR, Darisipudi MN, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012; 23(8): 1375-1388.
5. Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol. 2009; 113(1): e1-e7.
6. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007; 117(10): 2847-2859.
7. Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG. Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol. 2007; 18(6): 1732-1739.
8. Huugen D, Xiao H, van Esch A, et al. Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-b. Am J Pathol. 2005; 167(1): 47-58.
9. Liu B, Yang Y, Dai J, et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol. 2006; 177(10): 6880-6888.
10. Lartigue A, Colliou N, Calbo S, et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. J Immunol. 2009; 183(10): 6207-6216.
11. Coppo R, Camilla R, Amore A, et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin Exp Immunol. 2010; 159(1): 73-81.
12. Lepenies J, Eardley KS, Kienitz T, et al. Renal TLR4 mRNA expression correlates with inflammatory marker MCP-1 and profibrotic molecule TGF-p1 in patients with chronic kidney disease. Nephron Clin Pract. 2011; 119(2): c97-c104.
13. Lim BJ, Lee D, Hong SW, Jeong HJ. Toll-like receptor 4 signaling is involved in IgA-stimulated mesangial cell activation. Yonsei Med J. 2011; 54(4): 610-615.
14. Lovett DH, Bursten SL, Gemsa D, Bessler W, Resch K, Ryan JL. Activation of glomerular mesangial cells by gram-negative bacterial cell wall components. Am J Pathol. 1988; 133(3): 472-484.
15. Imaizumi T, Mori F, Yagihashi N, et al. Retinoic-acid inducible gene-I (RIG-I) and diseases. Hirosaki Med J. 2007; 59(Suppl.): S137-S142.
16. Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB. MDA-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent AT Pase activity and melanoma growth-suppressive properties. Proc Natl Acad USA. 2002; 99(2): 637-642.
17. Schwer B. A new twist on RNA helicases: DExH/D box proteins as RNPases. Nat Struct Biol. 2001; 8(2): 113-116.
18. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004; 5(7): 730-737.
19. Imaizumi T, Tanaka H, Matsumiya T, et al. Retinoic acidinducible gene-I is induced by double-stranded RNA and regulates the expression of CCL5 in human mesangial cells. Nephrol Dial Transplant. 2010; 25: 3534-3539.
20. Imaizumi T, Aizawa-Yashiro T, Tsuruga K, et al. Melanoma differentiation-associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases. Tohoku J Exp Med. 2012; 228(1): 17-26.
21. Imaizumi T, Aratani S, Nakajima T, et al. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem Biophys Res Commun. 2002; 292(1): 274-279.
22. Kubota K, Sakaki H, Imaizumi T, et al. Retinoic acid-inducible gene-I is induced in gingival fibroblasts by lipopolysaccharide or poly IC: possible roles in interleukin-1o,-6 and-8 expression. Oral Microbiol Immunol. 2006; 21(6): 399-406.
23. Kong L, Sun L, Zhang H, et al. An essential role for RIG-I in toll-like receptor-stimulated phagocytosis. Cell Host Microbe. 2009; 6(2): 150-161.
24. Imaizumi T, Sashinami H, Mori F, et al. Listeria monocytogenes induces the expression of retinoic acid-inducible gene-I. Microbiol Immunol. 2006; 50(10): 811-815.
25. Tatsuta T, Imaizumi T, Shimoyama T, et al. Expression of melanoma differentiation associated gene 5 is increased in human gastric mucosa infected with Helicobacter pylori. J Clin Pathol. 2012; 65(9): 839-843.
26. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol. 2010; 87(6): 989-999.
27. Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett. 2008; 121(1): 61-73.
28. Tsai CY, Wu TH, Yu CL, Chou CT. The in vitro immunomodulatory effects of sulfasalazine on human polymorphonuclear leukocytes, mononuclear cells, and cultured glomerular mesangial cells. Life Sci. 2000; 67(10): 1149-1161.
29. Gómez-Chiarri M, Hamilton TA, Egido J, Emancipator SN. Expression of IP-10, a lipopolysaccharide-and interferon-a-inducible protein, in murine mesangial cells in culture. Am J Pathol. 1993; 142(2): 433-439.
30. Suzuki K, Imaizumi T, Tsugawa K, Ito E, Tanaka H. Expression of retinoic acid-inducible gene-I in lupus nephritis. Nephrol Dial Transplant. 2007; 22(8): 2407-2409.
31. Tsugawa K, Oki E, Suzuki K, Imaizumi T, Ito E, Tanaka H. Expression of mRNA for functional molecules in urinary sediment in glomerulonephritis. Pediatr Nephrol. 2008; 23(3): 395-401.
32. Anders H-J, Lichtnekert J, Allam R. Interferon-33and-aain kidney inflammation. Kidney Int. 2010; 77(10): 848-854.
33. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-oB by Toll-like receptor 3. Nature. 2001; 413(6857): 732-738.
34. Kawai T, Akira S. Signaling to NF-B by Toll-like receptors. Trends Mol Med. 2007; 11(11): 460-469.
35. Wagoner J, Austin M, Green J, et al. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection. J Virol. 2007; 81(1): 309-318.
36. Das L, Brunner HI. Biomarkers for renal disease in childhood. Curr Rheumatol Rep. 2009; 11(3): 218-225.
37. Reyes-Thomas J, Blanco I, Putterman C. Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol. 2011; 40(3): 138-150.
38. Furuichi K, Kaneko S, Wada T. Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease. Clin Exp Nephrol. 2009; 13(1): 9-14.